Biology Reference
In-Depth Information
160. Vita C, Vizzavona J, Drakopoulou E,
et al
. (1998) Novel miniproteins
engineered by the transfer of active sites to small natural scaffolds.
Biopolymers
47
: 93-100.
161. Vita C, Drakopoulou E, Vizzavona J,
et al
. (1999) Rational engineer-
ing of a miniprotein that reproduces the core of the CD4 site interact-
ing with HIV-1 envelope glycoprotein.
Proc Natl Acad Sci USA
96
:
13091-13096.
162. Martin L, Stricher F, Misse D,
et al
. (2003) Rational design of a CD4
mimic that inhibits HIV-1 entry and exposes cryptic neutralization epi-
topes.
Nat Biotechnol
21
: 71-76.
163. Fouts T, Godfrey K, Bobb K,
et al
. (2002) Crosslinked HIV-1 enve-
lope-CD4 receptor complexes elicit broadly cross-reactive neutralizing
antibodies in rhesus macaques.
Proc Natl Acad Sci USA
99
:
11842-11847.
164. Fouts TB, Godfrey K, Syed A,
et al
. (2003) Structural Characterization
and Immunogenicity of a Single Chain Polypeptide Analogue of the
HIV-1 gp120-CD4 Receptor Complex Using a CD4 Mimic Protein,
CD4M9.
AIDS Vaccine
56
(Abstract 39).
165. Guo Q, Ho HT, Dicker I,
et al.
(2003) Biochemical and genetic char-
acterizations of a novel human immunodeficiency virus type 1 inhibitor
that blocks gp120-CD4 interactions.
J Virol
77
: 10528-10536.
166. Kwong PD, Wyatt R, Robinson J,
et al.
(1998) Structure of an HIV
gp120 envelope glycoprotein in complex with the CD4 receptor and a
neutralizing human antibody.
Nature
393
: 648-659.
167. Huang CC, Tang M, Zhang MY,
et al
. (2005) Structure of a V3-con-
taining HIV-1 gp120 core.
Science
310
: 1025-1028.
168. Malenbaum SE, Yang D, Cavacini L,
et al
. (2000) The N-terminal V3
loop glycan modulates the interaction of clade A and B human
immunodeficiency virus type 1 envelopes with CD4 and chemokine
receptors.
J Virol
74
: 11008-11016.
169. Reitter JN, Means RE, Desrosiers RC. (1998) A role for carbohydrates
in immune evasion in AIDS.
Nat Med
4
: 679-684.
170. McCaffrey RA, Saunders C, Hensel M, Stamatatos L. (2004) N-linked
glycosylation of the V3 loop and the immunologically silent face of
gp120 protects human immunodeficiency virus type 1 SF162 from
neutralization by anti-gp120 and anti-gp41 antibodies.
J Virol
78
:
3279-3295.
171. Pantophlet R, Ollmann Saphire E, Poignard P,
et al
. (2003) Fine map-
ping of the interaction of neutralizing and nonneutralizing monoclonal
